EUVIMEDEUVIMED entdecken
Crossref

Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study

Denita Williams, Mallikarjuna S Basavarajappa, Sonja A Rasmussen, Suzanne Morris, Donald Mattison, Animal Models of Pregnancy Working Group

Birth Defects Research Part A: Clinical and Molecular Teratology · 2014-10 · 100 (10) · 806-810

DOI: 10.1002/bdra.23319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research Part A: Clinical and Molecular Teratology, online erschienen am 08.10.2014. Verfasst von Denita Williams und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas; Huntingdon Li…. Hauptthemen laut MEDLINE: Disease Models, Animal, Pharmacokinetics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: FDA Medical Countermeasures Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The U.S. Food and Drug Administration (FDA) and other federal agencies partner to ensure that medical countermeasures (e.g., drug therapies and vaccines) are available for public health emergencies (FDA, 2014). Despite continuing progress, providing medical countermeasures and treatment guidelines for certain populations (e.g., pregnant women) is challenging due to the lack of clinical and/or animal data. Thus, a workshop was convened to discuss animal models of pregnancy for the evaluation of disease progression and medical countermeasures. Birth Defects Research (Part A) 100:806–810, 2014. © 2014 Wiley Periodicals, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalPharmacokineticsAnimalsDisease ProgressionEducationFemaleHumansInfluenza, HumanMicePregnancyUnited StatesUnited States Food and Drug Administration

Stichwörter der Autor:innen

animal modelsinfluenzamedical countermeasuresoseltamivir carboxylateoseltamivir phosphatepregnancy

Autor:innen und Institutionen

  • Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas; Huntingdon Life Sciences, Inc., Somerset, New Jersey.

Förderung

  • FDA Medical Countermeasures Initiative

Zitieren

APA

Williams, D., Basavarajappa, M. S., Rasmussen, S. A., Morris, S., Mattison, D., & Animal Models of Pregnancy Working Group (2014). Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study. Birth Defects Research Part A: Clinical and Molecular Teratology, 100(10), 806-810. https://doi.org/10.1002/bdra.23319

Vancouver

Williams D, Basavarajappa MS, Rasmussen SA, Morris S, Mattison D, Animal Models of Pregnancy Working Group. Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study. Birth Defects Research Part A: Clinical and Molecular Teratology. 2014;100(10):806-810. doi:10.1002/bdra.23319

BibTeX
@article{Williams2014,
  author = {Williams, Denita and Basavarajappa, Mallikarjuna S and Rasmussen, Sonja A and Morris, Suzanne and Mattison, Donald and Animal Models of Pregnancy Working Group, Animal Models of Pregnancy Working Group},
  title = {Highlights from the United States Food and Drug Administration's public workshop on the development of animal models of pregnancy to address medical countermeasures in an “at‐risk” population of pregnant women: Influenza as a case study},
  journal = {Birth Defects Research Part A: Clinical and Molecular Teratology},
  year = {2014},
  volume = {100},
  number = {10},
  pages = {806--810},
  doi = {10.1002/bdra.23319}
}
Kostenlos starten →